本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/10/231 分钟阅读
ImmVira Presents Clinical Data from Three Bladder Cancer Studies at ESMO 2026
本地自动翻译 · 来源原始语言
摘要
SUZHOU, China, Oct. 22, 2026 — ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic immunotherapy candidate, MVR-T3011, will be pre…
来源原始语言: PR Newswire — Global News Releases打开原始公告 →